Entering text into the input field will update the search result below

Sarepta Therapeutics Q1 net loss improves by 12%

  • Sarepta Therapeutics (NASDAQ:SRPT -6.5%) Q1 results: Revenues: $0; R&D Expense: $38.8M (-1.0%); SG&A: $20.9M (-7.9%); Operating Loss: ($59.7M) (+3.6%); Net Loss: ($59.8M) (+2.9%); Loss Per Share: ($1.31) (+12.1%); Non-GAAP Loss Per Share: ($1.15) (unch); Quick Assets: $129.2M (-32.9%).
  • No guidance given.

Recommended For You

More Trending News

About SRPT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SRPT--
Sarepta Therapeutics, Inc.